Adams Street Partners LLC Corvus Pharmaceuticals, Inc. Transaction History
Adams Street Partners LLC
- $93.5 Million
- Q4 2024
A detailed history of Adams Street Partners LLC transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Adams Street Partners LLC holds 3,275,616 shares of CRVS stock, worth $14.1 Million. This represents 18.22% of its overall portfolio holdings.
Number of Shares
3,275,616
Previous 3,275,616
-0.0%
Holding current value
$14.1 Million
Previous $17.3 Million
1.51%
% of portfolio
18.22%
Previous 10.6%
Shares
3 transactions
Others Institutions Holding CRVS
# of Institutions
102Shares Held
38.1MCall Options Held
2.75MPut Options Held
1.17M-
Orbimed Advisors LLC San Diego, CA6.94MShares$29.9 Million0.98% of portfolio
-
Samlyn Capital, LLC New York, NY6.67MShares$28.7 Million0.56% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.03MShares$13.1 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY2.68MShares$11.5 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$10.6 Million0.0% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $201M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...